Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Nominated Adviser Change of Name

17th Feb 2010 16:05

RNS Number : 3050H
Cyprotex PLC
17 February 2010
 



 

 

Cyprotex PLC

 

Nominated Adviser Change of Name

 

This announcement is at the request of the nominated adviser firm.

Noble & Company Limited has changed its name to Execution Noble & Company Limited ("Execution Noble").

If you have any questions relating to the above, please contact Execution Noble on +44 (0) 7456 9191

 

 

For further information:

 

Cyprotex PLC

Dr Anthony Baxter, Chief Executive Officer

Tel: +44 (0) 1625 505 100

John Dootson, Chief Financial Officer

www.cyprotex.com

[email protected]

 

Execution Noble & Company Limited

John Llewellyn-Lloyd

[email protected]

Tel: +44 (0) 20 7456 9191

Sam Reynolds

[email protected]

www.execution-noble.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFIRFSIDLII

Related Shares:

CRX.L
FTSE 100 Latest
Value8,275.66
Change0.00